TWO SIGMA INVESTMENTS, LP - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$704,333
-71.4%
120,605
-67.2%
0.00%
-75.0%
Q3 2022$2,465,000
+145.5%
367,952
+54.3%
0.01%
+166.7%
Q2 2022$1,004,000
+2410.0%
238,476
+1887.3%
0.00%
Q1 2022$40,000
-86.0%
12,000
-86.8%
0.00%
-100.0%
Q4 2021$286,000
+140.3%
90,900
+149.6%
0.00%
Q3 2021$119,000
-37.4%
36,424
-19.1%
0.00%
Q2 2021$190,000
-76.6%
45,000
-72.3%
0.00%
-100.0%
Q1 2021$811,000
+123.4%
162,597
+465.5%
0.00%
+100.0%
Q4 2020$363,000
+14.9%
28,753
-10.7%
0.00%0.0%
Q3 2020$316,000
-28.0%
32,192
-27.1%
0.00%
-50.0%
Q2 2020$439,000
-8.7%
44,131
-18.8%
0.00%
-50.0%
Q1 2020$481,000
-31.1%
54,359
-28.1%
0.00%
+100.0%
Q4 2019$698,000
-3.2%
75,654
-38.3%
0.00%0.0%
Q3 2019$721,000
-42.6%
122,559
+17.0%
0.00%
-50.0%
Q2 2019$1,257,000
+208.8%
104,756
+210.4%
0.00%
+300.0%
Q1 2019$407,000
-21.9%
33,750
-18.8%
0.00%
-50.0%
Q4 2018$521,000
-50.5%
41,539
-41.4%
0.00%
-33.3%
Q3 2018$1,052,000
+46.9%
70,906
+66.6%
0.00%
+50.0%
Q2 2018$716,000
-81.8%
42,550
-72.0%
0.00%
-84.6%
Q4 2017$3,929,000
+371.1%
151,875
+210.6%
0.01%
+333.3%
Q1 2017$834,000
+94.9%
48,900
+56.0%
0.00%
+50.0%
Q1 2016$428,000
-59.7%
31,340
-55.3%
0.00%
-60.0%
Q1 2015$1,062,000
+76.4%
70,096
+55.2%
0.01%
+66.7%
Q4 2014$602,00045,1630.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,200,000$37,532,0007.45%
BVF INC/IL 2,336,609$39,863,0006.78%
ISZO CAPITAL MANAGEMENT LP 152,988$2,610,0004.54%
SENZAR ASSET MANAGEMENT, LLC 416,845$7,111,0001.80%
INGALLS & SNYDER LLC 1,056,000$18,015,0000.96%
Lyon Street Capital, LLC 86,011$1,467,0000.59%
DRIEHAUS CAPITAL MANAGEMENT LLC 430,982$7,353,0000.25%
AWM Investment Company, Inc. 137,212$2,340,0000.22%
ACUTA CAPITAL PARTNERS, LLC 49,051$837,0000.20%
Schonfeld Strategic Advisors LLC 61,831$1,055,0000.11%
View complete list of CONCERT PHARMACEUTICALS INC shareholders